The Convergent Science Cancer Consortium, a consortium using an unconventional approach that emphasizes the integration of diverse scientific disciplines, received a $3.2 million grant from the U.S. Department of Defense.
The FY25 Defense Appropriations Act is anticipated to provide funding for the Peer Reviewed Cancer Research Program to support innovative, high-impact cancer research.
